Journal Article10.1097/PAS.0000000000001025
Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Jérôme Verine,Delphine Colin,Mary Nheb,Dominique Prapotnich,Guillaume Ploussard,Xavier Cathelineau,François Desgrandchamps,Pierre Mongiat-Artus,Jean-Paul Feugeas,Jean-Paul Feugeas +9 more
58
TL;DR: Development and validated an architecture-based grading for clear cell renal cell carcinoma (ccRCC) in an observational retrospective cohort study including 506 tumors and found that architectural grade with 1 morphologic datum remained an independent predictor of CSS and was associated with the highest HR.
read more
Abstract: We developed and validated an architecture-based grading for clear cell renal cell carcinoma (ccRCC) in an observational retrospective cohort study including 506 tumors (principal cohort, n=254; validation cohort, n=252). Study endpoints were disease-free survival (DFS) and cancer-specific survival (CSS). Relationships with outcome were analyzed using Harrell concordance index, time-dependent receiver operating characteristic curve, area under curve, and Cox regression model. An architecture-based grading was devised on positive likelihood ratio (LR+) for DFS at 50 months as follows: grade 1 (LR+<0.8), cystic, compact, acinar, clear cell papillary RCC-like, and/or regressive patterns; grade 2 (1.2≤LR+<5), large nest, alveolar, papillary, chromophobe/oncocytic cell-like, eosinophilic hyaline globule, and/or intratumoral inflammatory reaction patterns; grade 3 (5≤LR+<10), rhabdoid, tumor giant cell, enlarged vascular space, and/or hereditary leiomyomatosis renal cell carcinoma (HLRCC)-like patterns; grade 4 (LR+≥10), sarcomatoid, infiltrative growth patterns, and lymphatic invasion. In the principal cohort, 3-tier (grades 1-2, 3, and 4) and 4-tier architectural scores outperformed World Health Organization/International Society of Urological Pathology, and World Health Organization/ International Society of Urological Pathology+necrosis gradings for DFS and CSS, and constituted an independent predictor for DFS (hazard ratio [HR]=5.91; P<6.7E-10) and CSS (HR=4.49; P=2.2E-03), retained in the localized (pT1-3N0M0) ccRCC subgroup (HR=6.10; P=1.3E-07 for DFS, and HR=20.09; P=9.4E-05 for CSS). On comparing with integrated staging systems, architectural grade with 1 morphologic datum remained an independent predictor of CSS, as did University of California Los Angeles Integrated Staging System and SSIGN, and was associated with the highest HR (HR=2.60; P=9.1E-04 in all patients; HR=4.38; P=2.0E-05 in the localized ccRCC subgroup). Architecture-based score for ccRCC outperforms all other morphologic grading systems and constitutes an independent predictor for DFS and CSS. As the predictive values of 3-tier and 4-tier architecture-based scores were similar throughout the study, we proposed to keep the simplified version as the final score, and to define 3 risk groups as follows: low risk (grades 1 to 2), intermediate risk (grade 3), and high risk (grade 4).
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Grading of renal cell carcinoma.
TL;DR: It has been recommended that grading of RCC should be based upon nucleolar prominence/eosinophilia for grades 1–3, while grade 4 requires nuclear anaplasia (including tumour giant cells, sarcomatoid differentiation and/or rhabdoid morphology).
305
WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies.
Anne Y. Warren,David J. Harrison +1 more
TL;DR: Much has been done to standardise pathological assessment of renal cell carcinomas in recent years, but there still remain areas of difficulty in classification and grading of these heterogeneous tumours.
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Kiril Trpkov,Ondrej Hes,Sean R. Williamson,Adebowale J. Adeniran,Abbas Agaimy,Reza Alaghehbandan,Mahul B. Amin,Pedram Argani,Ying-Bei Chen,Liang Cheng,Jonathan I. Epstein,John C. Cheville,Eva Compérat,Isabela Werneck da Cunha,Jennifer B. Gordetsky,Sounak Gupta,Huiying He,Michelle S. Hirsch,Peter A. Humphrey,Payal Kapur,Fumiyoshi Kojima,José I. López,Fiona Maclean,Cristina Magi-Galluzzi,Jesse K. McKenney,Rohit Mehra,Santosh Menon,George J. Netto,Christopher G. Przybycin,Priya Rao,Qiu Rao,Victor E. Reuter,Rola Saleeb,Rajal B. Shah,Steven C. Smith,Satish K. Tickoo,Maria S. Tretiakova,Lawrence D. True,Virginie Verkarre,Sara E. Wobker,Ming Zhou,Anthony J. Gill,Anthony J. Gill,Anthony J. Gill +43 more
TL;DR: The authors in this article reviewed recent advances in renal neoplasia, particularly post-2016 World Health Organization (WHO) classification, to provide an update on existing entities, including diagnostic criteria, molecular correlates, and updated nomenclature.
189
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.
Yize Li,Tung-Shing M. Lih,Saravana M. Dhanasekaran,Rahul Mannan,Lijun Chen,Marcin Cieslik,Yige Wu,Rita Jui-Hsien Lu,David J. Clark,Iga Kołodziejczak,Runyu Hong,Siqi Chen,Yanyan Zhao,Seema Chugh,Wagma Caravan,Nataly Naser Al Deen,Noshad Hosseini,Chelsea J. Newton,Karsten Krug,Yuanwei Xu,Kyung-Cho Cho,Yi-Kang Hu,Yuping Zhang,Chandan Kumar-Sinha,Weiping Ma,Anna Calinawan,Matthew A. Wyczalkowski,Michael C. Wendl,Yuefan Wang,Shenghao Guo,Cissy Zhang,Anne Le,Aniket Dagar,Alex Hopkins,Han Wool Cho,Felipe da Veiga Leprevost,Xiaojun Jing,Guo Ci Teo,Wenke Liu,Melissa A. Reimers,Russell K. Pachynski,Alexander J. Lazar,Arul M. Chinnaiyan,Brian A. Van Tine,Bing Zhang,Karin D. Rodland,Gad Getz,D. R. Mani,Pei Wang,Feng Chen,Galen Hostetter,Mathangi Thiagarajan,W. Marston Linehan,David Fenyö,Scott D. Jewell,Gilbert S. Omenn,Rohit Mehra,Maciej Wiznerowicz,Ana I. Robles,Mehdi Mesri,Tara Hiltke,Eunkyung An,Henry J Quintero Rodríguez,Daniel W. Chan,Christopher J. Ricketts,Alexey I. Nesvizhskii,Hui Zhang,Li Ding,Alicia Francis,Amanda G. Paulovich,Andrzej Antczak,Anthony Green,Antonio Colaprico,A. Ari Hakimi,Barbara L. Pruetz,Barbara Hindenach,Birendra Kumar Yadav,Boris Reva,Brenda Fevrier-Sullivan,Brian J. Druker,Cezary Szczylik,Charles A. Goldthwaite,Chet Birger,Corbin D. Jones,Daniel C. Rohrer,Darlene Tansil,David Chesla,David I. Heiman,Elizabeth R. Duffy,Erin Schadt,Francesca Petralia,Gabriel Bromiński,Gabriela Quiroga-Garza,George S. Wilson,Ginny Li,Grace Zhao,Y. Hsiao,James J. Hsieh,Jan Lubinski,Jasmin H. Bavarva,Jasmine Huang,Jason Hafron,Jennifer M. Eschbacher,Jennifer Hon,Jesse Francis,John Freymann,Josh N. Vo,Joshua M. Wang,Justin Kirby,Kakhaber Zaalishvili,Karen A. Ketchum,Katherine A. Hoadley,Ki Sung Um,Liqun Qi,Marcin J. Domagalski,Matthew F. Tobin,Maureen Dyer,Meenakshi Anurag,Melissa Borucki,Michael A. Gillette,Michael J. Birrer,Michael Ittmann,Michael H.A. Roehrl,Michael Schnaubelt,Michael V. Smith,Mina M. Fam,Nancy Roche,Negin Vatanian,Nicollette S. Maunganidze,Olga Potapova,Oxana Paklina,Pamela VanderKolk,Patricia Castro,Paweł Murawa,Pushpa Hariharan,Qin Li,Qing Kay Li,Rajiv Dhir,Ratna R. Thangudu,Rebecca Montgomery,Richard D. Smith,Sailaja Mareedu,Samuel H. Payne,Sandra Cerda,Sandra Cottingham,Sarah Haynes,Shankha Satpathy,Shannon Richey,Shilpi Singh,Shirley Tsang,Shuang Cai,Song Cao,Stacey Gabriel,Steven A. Carr,Tao Li,Thomas Bauer,Toan Thuy Le,Xi Shan Chen,Xu Zhang,Yvonne Shutack,Zhenyu Zhang +160 more
TL;DR: In this article , integrative histopathologic, proteogenomic, and metabolomic analyses were performed on 305 ccRCC tumor segments and 166 paired adjacent normal tissues from 213 cases.
111
Pancreatic tropism of metastatic renal cell carcinoma
Nirmish Singla,Zhiqun Xie,Ze Zhang,Ming Gao,Qurratulain Yousuf,Oreoluwa Onabolu,Tiffani McKenzie,Vanina Tcheuyap,Yuanqing Ma,Jacob Choi,Renée M. McKay,Alana Christie,Oscar Reig Torras,Isaac Bowman,Vitaly Margulis,Ivan Pedrosa,Christopher G. Przybycin,Tao Wang,Payal Kapur,Brian I. Rini,James Brugarolas +20 more
TL;DR: RCC metastatic to the pancreas is characterized by indolent biology, heightened angiogenesis, and an uninflamed stroma, likely underlying its good prognosis, sensitivity to antiangiogenic therapies, and refractoriness to ICI.
74
References
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
TL;DR: A representation and interpretation of the area under a receiver operating characteristic (ROC) curve obtained by the "rating" method, or by mathematical predictions based on patient characteristics, is presented and it is shown that in such a setting the area represents the probability that a randomly chosen diseased subject is (correctly) rated or ranked with greater suspicion than a random chosen non-diseased subject.
21.8K
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
TL;DR: This review summarizes the most significant differences between the newly published classification of urogenital tumours and the prior version for renal, penile, and testicular tumours.
2.8K
Prognostic significance of morphologic parameters in renal cell carcinoma.
TL;DR: Nuclear grade was the most significant prognostic criterion for the outcome of State I renal cell carcinoma, more effective than each of the other parameters in predicting development of distant metastasis following nephrectomy.
2.6K
The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia
John R. Srigley,Brett Delahunt,John N. Eble,Lars Egevad,Jonathan I. Epstein,David J. Grignon,Ondrej Hes,Holger Moch,Rodolfo Montironi,Satish K. Tickoo,Ming Zhou,Pedram Argani,Anila Abraham,Adebowale J. Adeniran,Khalid Ahmed,Hikmat Al Ahmadie,Ferran Algaba,Robert W. Allan,Mahul B. Amin,Ulrika Axcrona,Marc Barry,Dilek Ertoy Baydar,Louis R. Bégin,Daniel M. Berney,Peter Bethwaite,Athanase Billis,Ruth Birbe,Stephen M. Bonsib,David G. Bostwick,Fadi Brimo,Helen P. Cathro,Ying-Bei Chen,Liang Cheng,John C. Cheville,Yong Mee Cho,Ai Ying Chuang,Cynthia Cohen,Henry Crist,Warick Delprado,Fang Ming Deng,Andrew Evans,Oluwole Fadare,Daniel A. Fajardo,Sara M. Falzarano,Samson W. Fine,Stewart Fleming,Eddie Fridman,Bungo Furusato,Masoud Ganji,Masoumeh Ghayouri,Giovanna A. Giannico,Neriman Gokden,David J. Griffiths,Nilesh S. Gupta,Omar Hameed,Michelle S. Hirsch,Jiaoti Huang,Wei Huang,Christina Hulsbergen Van De Kaa,Peter A. Humphrey,Sundus Hussein,Kenneth A. Iczkowski,Rafael E. Jimenez,Edward C. Jones,Laura Irene Jufe,James G. Kench,Masatoshi Kida,Glen Kristiansen,Lakshmi P. Kunju,Zhaoli Lane,Mathieu Latour,Claudio Lewin,Kathrine Lie,Josep Lloreta,Barbara Loftus,Antonio Lopez-Beltran,Fiona Maclean,Cristina Magi-Galluzzi,Guido Martignoni,Teresa McHale,Jesse K. McKenney,Maria Merino,Rose Miller,Hiroshi Miyamoto,Hedwig Murphy,John N. Nacey,Tipu Nazeer,Gabriella Nesi,George J. Netto,Peter W. Nichols,Marie O'Donnell,Semra Olgac,Roberto Orozco,Adeboye O. Osunkoya,Aysim Ozagari,Chin Chen Pan,Anil V. Parwani,Joanna Perry-Keene,Constantina Petraki,Maria M. Picken,Maria Pyda-Karwicka,Victor E. Reuter,Katayoon Rezaei,Nathalie Rioux-Leclercq,Brian D. Robinson,Stephen Rohan,Ruben Ronchetti,Laurie Russell,Hemamali Samaratunga,Marina Scarpelli,Ahmed Shabaik,Rajal B. Shah,Jonathan H Shanks,Steven S. Shen,Maria Shevchuk,Mathilde Sibony,Bhuvana Srinivasan,Martin Susani,Sueli Suzigan,Joan Sweet,Hiroyuki Takahashi,Pheroze Tamboli,Puay Hoon Tan,Isabel Trias,Kiril Trpkov,Larry True,Toyonori Tsuzuki,Funda Vakar-Lopez,Theo H. van der Kwast,Cheng Wang,Anne Y. Warren,Jorge L. Yao,Asli Yilmaz,Jin Zhao,Debra L. Zynger +134 more
TL;DR: The classification working group of the International Society of Urological Pathology consensus conference on renal neoplasia was in charge of making recommendations regarding additions and changes to the current World Health Organization Classification of Renal Tumors, with consensus that 5 entities should be recognized as new distinct epithelial tumors within the classification system.
1K
Simplifying Likelihood Ratios
TL;DR: This article describes a simpler method of interpreting likelihood ratios, one that avoids calculators, nomograms, and conversions to “odds” of disease.
Related Papers (5)
Brett Delahunt,John C. Cheville,Guido Martignoni,Peter A. Humphrey,Cristina Magi-Galluzzi,Jesse K. McKenney,Lars Egevad,Ferran Algaba,Holger Moch,David J. Grignon,Rodolfo Montironi,John R. Srigley,John R. Srigley,Anila Abraham,Adebowale J. Adeniran,Khalid Ahmed,Hikmat Al Ahmadie,Robert W. Allan,Mahul B. Amin,Pedram Argani,Ulrika Axcrona,Marc Barry,Dilek Ertoy Baydar,Louis R. Bégin,Daniel M. Berney,Peter Bethwaite,Athanase Billis,Ruth Birbe,Stephen M. Bonsib,David G. Bostwick,Fadi Brimo,Helen P. Cathro,Ying-Bei Chen,Liang Cheng,Yong Mee Cho,Ai Ying Chuang,Cynthia Cohen,Henry Crist,Warick Delprado,Fang Ming Deng,Jonathan I. Epstein,Andrew Evans,Oluwole Fadare,Daniel A. Fajardo,Sara M. Falzarano,Samson W. Fine,Stewart Fleming,Eddie Fridman,Bungo Furusato,Masoud Ganji,Masoumeh Ghayouri,Giovanna A. Giannico,Neriman Gokden,David J. Griffiths,Nilesh S. Gupta,Omar Hameed,Ondrej Hes,Michelle S. Hirsch,Jiaoti Huang,Wei Huang,Christina Hulsbergen Van De Kaa,Sundus Hussein,Kenneth A. Iczkowski,Rafael E. Jimenez,Edward C. Jones,Laura Irene Jufe,James G. Kench,Masatoshi Kida,Glen Kristiansen,Lakshmi P. Kunju,Zhaoli Lane,Mathieu Latour,Claudio Lewin,Kathrine Lie,Josep Lloreta,Barbara Loftus,Antonio Lopez-Beltran,Fiona Maclean,Teresa McHale,Maria Merino,Rose Miller,Hiroshi Miyamoto,Hedwig Murphy,John N. Nacey,Tipu Nazeer,Gabriella Nesi,George J. Netto,Peter W. Nichols,Marie O'Donnell,Semra Olgac,Roberto Orozco,Adeboye O. Osunkoya,Aysim Ozagari,Chin Chen Pan,Anil V. Parwani,Joanna Perry-Keene,Constantina Petraki,Maria M. Picken,Maria Pyda-Karwicka,Victor E. Reuter,Katayoon Rezaei,Nathalie Rioux-Leclercq,Brian D. Robinson,Stephen Rohan,Ruben Ronchetti,Laurie Russell,Marina Scarpelli,Ahmed Shabaik,Rajal B. Shah,Jonathan H Shanks,Steven S. Shen,Maria Shevchuk,Mathilde Sibony,Bhuvana Srinivasan,Martin Susani,Sueli Suzigan,Joan Sweet,Hiroyuki Takahashi,Puay Hoon Tan,Satish K. Tickoo,Isabel Trias,Larry True,Toyonori Tsuzuki,Funda Vakar-Lopez,Theo H. van der Kwast,Cheng Wang,Anne Y. Warren,Jorge L. Yao,Asli Yilmaz,Jin Zhao,Ming Zhou,Debra L. Zynger +131 more